Search research articles
Contact Us
Filters
Showing results (101-110 of 154) with videos related to
Page
of 16
Sort By:
European Journal of Breast Health
|
October 5, 2023
Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention
Fatma Nihan Akkoc Mustafayev, Diane D Liu, Angelica M Gutierrez, et al.
Nature Communications
|
March 8, 2024
GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer
Zu Ye, Shengfeng Xu, Yin Shi, et al.
Cancer Cell
|
August 25, 2004
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Yoichi Nagata, Keng-Hsueh Lan, Xiaoyan Zhou, et al.
Stem Cells (Dayton, Ohio)
|
August 12, 2015
Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases
Deepak Kanojia, Irina V Balyasnikova, Ramin A Morshed, et al.
Clinical & Experimental Metastasis
|
May 19, 2019
The importance of developing therapies targeting the biological spectrum of metastatic disease
Andries Zijlstra, Ariana Von Lersner, Dihua Yu, et al.
Nature Communications
|
February 2, 2024
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma
Chunxiao Liu, Chenhao Zhou, Weiya Xia, et al.
Cancer Research
|
September 16, 2010
Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis
Xiaoyun Cheng, Weiya Xia, Jer-Yen Yang, et al.
Cancer Cell
|
September 8, 2009
14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition
Jing Lu, Hua Guo, Warapen Treekitkarnmongkol, et al.
Cell Research
|
March 29, 2014
Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors
Ozgur Sahin, Qingfei Wang, Samuel W Brady, et al.
Nature Medicine
|
March 15, 2011
Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
Siyuan Zhang, Wen-Chien Huang, Ping Li, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 154) with videos related to
Sort By:
Page
of 16
European Journal of Breast Health
|
October 5, 2023
Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention
Fatma Nihan Akkoc Mustafayev, Diane D Liu, Angelica M Gutierrez, et al.
Nature Communications
|
March 8, 2024
GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer
Zu Ye, Shengfeng Xu, Yin Shi, et al.
Cancer Cell
|
August 25, 2004
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Yoichi Nagata, Keng-Hsueh Lan, Xiaoyan Zhou, et al.
Stem Cells (Dayton, Ohio)
|
August 12, 2015
Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases
Deepak Kanojia, Irina V Balyasnikova, Ramin A Morshed, et al.
Clinical & Experimental Metastasis
|
May 19, 2019
The importance of developing therapies targeting the biological spectrum of metastatic disease
Andries Zijlstra, Ariana Von Lersner, Dihua Yu, et al.
Nature Communications
|
February 2, 2024
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma
Chunxiao Liu, Chenhao Zhou, Weiya Xia, et al.
Cancer Research
|
September 16, 2010
Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis
Xiaoyun Cheng, Weiya Xia, Jer-Yen Yang, et al.
Cancer Cell
|
September 8, 2009
14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition
Jing Lu, Hua Guo, Warapen Treekitkarnmongkol, et al.
Cell Research
|
March 29, 2014
Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors
Ozgur Sahin, Qingfei Wang, Samuel W Brady, et al.
Nature Medicine
|
March 15, 2011
Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
Siyuan Zhang, Wen-Chien Huang, Ping Li, et al.
Page
of 16